High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 12, 2000, Pages 2619-2624

  Paultre, Furcy ^a   Pearson, Thomas A ^b,c   Weil, Henry F C ^b   Tuck, Catherine H ^a   Myerson, Merle ^b   Rubin, Jill ^a   Francis, Charles K ^d   Marx, Herbert F ^b   Philbin, Edward F ^b   Reed, Roberta G ^b   Berglund, Lars ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b BASSETT RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d HARLEM HOSPITAL CENTER   (United States)

Author keywords

African Americans; Angiography; Coronary artery disease; Genetic variation; Lipoprotein(a)

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MALE; NEGRO; PRIORITY JOURNAL; SMOKING;

EID: 0033664654     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.12.2619     Document Type: Article

References (37)

1. The mysteries of lipoprotein(a)
2. Lp(a) lipoprotein as a risk factor for myocardial infarction
3. Lipoprotein Lp(a) and the risk for myocardial infarction
4. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women: The Framingham Heart Study
5. Lipoprotein (a) and risk of coronary heart disease in men: The lipid research clinics coronary primary prevention trial
6. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger: A prospective study
7. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants
8. Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women
9. Lipoprotein Lp(a) excess and coronary heart disease
10. A prospective study of lipoprotein(a) and the risk of myocardial infarction
11. Lipoprotein(a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants
12. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a general population sample of middle aged men
13. Lipoprotein(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: Results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS)
14. Lipoprotein(a) and apolipoprotein (a) phenotypes in Caucasians and African Americans: The CARDIA Study
15. No association between plasma lipoprorein(a) concentrations and the presence or absence of coronary atherosclerosis in African Americans
16. The apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans
17. Apo(a) isoforms predict risk for coronary heart disease: A study in six populations
18. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary artery disease
19. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age
20. Lp(a) concentration at d apo(a) isoform size: Relation to the presence of coronary artery disease in familial hypercholesterolemia
21. Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men <55 years of age
22. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their regulation to disease and prognosis after coronary by-pass surgery
23. Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication
24. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: Prospective results from the Bruneck Study
25. Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans
26. Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining
27. Expressed hypervariable polymorphism of apolipoprotein(a)
28. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field electrophoresis
29. Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease
30. Plasma lipoprotein(a) concentration and coronary artery disease in black patients compared with white patients
31. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms
32. Apolipoprotein(a) isoforms and coronary heart disease in men: A nested case-control study
33. Apolipoprotein(a) size polymorphism in young adults with ischemic stroke
34. Identification of 34 apolipoprotein(a) isoforms: Differential expression of apolipoprotein(a) alleles between American blacks and Whites
35. Lipoprotein(a) as a determinant of coronary heart disease in young women
36. Microvascular angina: Cardiovascular investigations regarding pathophysiology and management
37. Hormonal regulation of lipoprotein(a) levels: Effect of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women